estragon absolute

General Material Information

Preferred name	estragon absolute
Trivial Name	Tarragon oil
Short Description	artemisia dracunculus absolute
CAS Number	8016-88-4
FDA UNII	Search
Synonyms	artemisia aromatica absolute artemisia dracunculina absolute artemisia dracunculoides absolute artemisia dracunculoides var. dracunculina absolute artemisia dracunculus absolute artemisia dracunculus subsp. dracunculina absolute artemisia glauca absolute artemisia glauca var. megacephala absolute oligosporus dracunculus absolute tarragon absolute tarragon absolute (for fragrance) (Robertet) artemisia dracunculus l. absolute Tarragon oil Oils, tarragon Essential oils, tarragon Oils, essential, tarragon Estragon oil Artemisia dracunculus oil

US / EU / FDA / JECFA / FEMA / Scholar / Patents

Google Scholar	Start search
Google Books	Start search
Google Patents	Start search
Perfumer & Flavorists	Start search
EU Patents	Start search
PubMeb	Start search
NCBI	Start search

Literature & References

	artemisia dracunculus l. absolute
Canada Domestic Sub. List:	8016-88-4
Pubchem (sid):	135358337

Publications by PubMed
Artemisia dracunculus L. extract ameliorates insulin sensitivity by attenuating inflammatory signalling in human skeletal muscle culture.
Chemical characterization by GC-MS and in vitro activity against Candida albicans of volatile fractions prepared from Artemisia dracunculus, Artemisia abrotanum, Artemisia absinthium and Artemisia vulgaris.
Antinociceptive effect of the essential oil of tarragon (Artemisia dracunculus).
An extract of Artemisia dracunculus L. inhibits ubiquitin-proteasome activity and preserves skeletal muscle mass in a murine model of diabetes.
Toxicological and mutagenic analysis of Artemisia dracunculus (tarragon) extract.
LC-PDA-ESI/MS identification of the phenolic components of three compositae spices: chamomile, tarragon, and Mexican arnica.
Essential oil of tarragon (Artemisia dracunculus) antibacterial activity on Staphylococcus aureus and Escherichia coli in culture media and Iranian white cheese.
Effective cytochrome P450 (CYP) inhibitors isolated from tarragon (Artemisia dracunculus).
Proteomic analysis reveals cellular pathways regulating carbohydrate metabolism that are modulated in primary human skeletal muscle culture due to treatment with bioactives from Artemisia dracunculus L.
Bioactives of Artemisia dracunculus L. mitigate the role of ceramides in attenuating insulin signaling in rat skeletal muscle cells.
Comparative evaluation of two different Artemisia dracunculus L. cultivars for blood sugar lowering effects in rats.
Artemisia dracunculus L. (tarragon): a critical review of its traditional use, chemical composition, pharmacology, and safety.
Melanin biosynthesis inhibitors from Tarragon Artemisia dracunculus.
Qualitative variation of anti-diabetic compounds in different tarragon (Artemisia dracunculus L.) cytotypes.
Evaluation of PMI-5011, an ethanolic extract of Artemisia dracunculus L., on peripheral neuropathy in streptozotocin-diabetic mice.
Chemical composition of bioactive pressurized extracts of Romanian aromatic plants.
Survey of artemisinin production by diverse Artemisia species in northern Pakistan.
An extract of Artemisia dracunculus L. enhances insulin receptor signaling and modulates gene expression in skeletal muscle in KK-A(y) mice.
Carotenoid content of commonly consumed herbs and assessment of their bioaccessibility using an in vitro digestion model.
High-fat diet-induced neuropathy of prediabetes and obesity: effect of PMI-5011, an ethanolic extract of Artemisia dracunculus L.
Nematicidal activity of essential oils and volatiles derived from Portuguese aromatic flora against the pinewood nematode, Bursaphelenchus xylophilus.
Regulation of insulin action by an extract of Artemisia dracunculus L. in primary human skeletal muscle culture: a proteomics approach.
Efficient synthesis of flavanone glucuronides.
Acetylcholinesterase inhibitory activity and chemical composition of commercial essential oils.
Improved absorption and bioactivity of active compounds from an anti-diabetic extract of Artemisia dracunculus L.
Heavy metals in selected edible vegetables and estimation of their daily intake in Sanandaj, Iran.
Bioactives of Artemisia dracunculus L enhance cellular insulin signaling in primary human skeletal muscle culture.
Efficacy of dietary supplementation with botanicals on carbohydrate metabolism in humans.
Screening of chemical composition, antimicrobial and antioxidant activities of Artemisia essential oils.
Botanicals and the metabolic syndrome.
Comparative effects of Artemisia dracunculus, Satureja hortensis and Origanum majorana on inhibition of blood platelet adhesion, aggregation and secretion.
Inhibition of blood platelet adhesion, aggregation and secretion by Artemisia dracunculus leaves extracts.
Polyphenolic compounds from Artemisia dracunculus L. inhibit PEPCK gene expression and gluconeogenesis in an H4IIE hepatoma cell line.
A source of almost pure methyl chavicol: volatile oil from the aerial parts of Tagetes lucida (Asteraceae) cultivated in Costa Rica.
A TLC bioautographic assay for the detection of nitrofurantoin resistance reversal compound.
Composition of the volatile fraction of Ocotea bofo Kunth (Lauraceae) calyces by GC-MS and NMR fingerprinting and its antimicrobial and antioxidant activity.
Screening antimicrobial activity of various extracts of Artemisia dracunculus L.
Antihyperglycemic activity of Tarralin, an ethanolic extract of Artemisia dracunculus L.
Bioassay-guided isolation of aldose reductase inhibitors from Artemisia dracunculus.
Determination of the chemical composition and antioxidant activity of the essential oil of Artemisia dracunculus and of the antifungal and antibacterial activities of Turkish Artemisia absinthium, A. dracunculus, Artemisia santonicum, and Artemisia spicigera essential oils.
[Occupational allergy to mugwort].
Comparative screening of plant essential oils: phenylpropanoid moiety as basic core for antiplatelet activity.
[Studies on the chemical constituents of the essential oil of Artemisia dracunculus].
Anticonvulsant activity and chemical composition of Artemisia dracunculus L. essential oil.
Toxicological evaluation of the ethanolic extract of Artemisia dracunculus L. for use as a dietary supplement and in functional foods.
Antifungal 3-butylisocoumarins from Asteraceae-Anthemideae.
Antifungal constituents of the essential oil fraction of Artemisia dracunculus L. Var. dracunculus.
Alkamides from Artemisia dracunculus.
Evidence for an NIH shift as the origin of the apparently anomalous distribution of deuterium in estragole from Artemisia dracunculus.
Identification of benzodiazepines in Artemisia dracunculus and Solanum tuberosum rationalizing their endogenous formation in plant tissue.
Acetylenes and Other Constituents from Artemisia dracunculus.
Studies on the genotoxic properties of essential oils with Bacillus subtilis rec-assay and Salmonella/microsome reversion assay.
Evaluation of traditional plant treatments for diabetes: studies in streptozotocin diabetic mice.
Natural inhibitors of complement. III. Inactivation of the complement cascade in vitro by vegetal spices (Ocimum basilicum, Artemisia dracunculus and Thymus vulgaris).
A study of four medicinal plant complexes of Mexico and adjacent United States.
[Studies on the accumulation and composition of the volatile oils of Satureja hortensis L., Satureja montana L. and Artemisia dracunculus L. during ontogenesis. 2. Changes in the content and composition of the volatile oil].
[Studies on the accumulation and composition of volatile oils in Satureja hortensis L., Satureja montana L. and Artemisia dracunculus L. during ontogenesis. 1. Review of literature, thin-layer and gas-chromatographic studies].

Other Information

Export Tariff Code:	3301.90.5000
Wikipedia:	View

Suppliers

A. Fakhry

Robertet

PhysChem Properties

Material listed in food chemical codex	No
Solubility
alcohol	Yes
water	No

Organoleptic Properties

Odor Type: Anise
sweet, anise, spicy, woody
General comment	At 100.00 %. sweet anise spice woody

Occurrences

Potential Uses

Applications	fragrance agents
Odor purposes	Anise , Herbal , Spice

Safety Information

Safety information

European information :
Most important hazard(s):
Xn - Harmful.
R 36/37/38 - Irritating to eyes, respiratory system, and skin. R 40/22 - Limited evidence of a carcinogenic effect, harmful if swallowed. R 65 - Harmful: may cause lung damage if swallowed. S 23 - Do not breath vapour. S 24/25 - Avoid contact with skin and eyes. S 26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S 36/37/39 - Wear suitable clothing, gloves and eye/face protection.

Hazards identification

Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
None found.
GHS Label elements, including precautionary statements

Pictogram

Hazard statement(s)
None found.
Precautionary statement(s)
None found.
Oral/Parenteral Toxicity:
oral-rat LD50 1900 mg/kg Food and Cosmetics Toxicology. Vol. 12, Pg. 709, 1974.
Dermal Toxicity:
skin-rabbit LD50 > 5 mL/kg Food and Cosmetics Toxicology. Vol. 12, Pg. 709, 1974.
Inhalation Toxicity:
Not determined

Safety in use information

Category:
fragrance agents
RIFM Fragrance Material Safety Assessment: Search
IFRA Code of Practice Notification of the 49th Amendment to the IFRA Code of Practice
contains the following IFRA (Annex) restricted components: (non-analysis max. level reference only)
7-methoxycoumarin	Max. Found: ≥5.00 % and Reason: Sentitization / Photo Sensitization
estragol	Max. Found:

Recommendation for estragon absolute flavor usage levels up to:
	not for flavor use.

Safety references

AIDS Citations:Search

Cancer Citations:Search

Toxicology Citations:Search

EPA Substance Registry Services (TSCA):8016-88-4

EPA ACToR:Toxicology Data

EPA Substance Registry Services (SRS):Registry

National Institute of Allergy and Infectious Diseases:Data

artemisia dracunculus l. absolute

Chemidplus:0008016884